NCT05406544

Brief Summary

Fibrous dysplasia (FD) is a congenital skeletal disorder with multiple complications such as bone pain, fractures, deformities and nerve compression. Few quantitative studies have demonstrated its physical, mental and social negative impacts on patients but none have qualitatively evaluated their global quality of life. Our hypothesis is that a better knowledge of the quality of life of FD patients should allow to target the actions to be implemented to improve patients'care. The main objective of this qualitative research is therefore to investigate the quality of life of FD patients through 2 approaches: a qualitative study with focus groups interviews addressing several themes: self-image, psychological and emotional well-being, difficulties and adaptative strategies; and a quantitative study to measure the impact of FD on quality of life and on olfaction (sometimes affected by nerve compression due to the disease) using standardized questionnaires Short Form 36 (SF36) and Self-reported Mini Olfactory Questionnaire (SELF-MOQ).

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
149

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Nov 2022

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

June 2, 2022

Completed
4 days until next milestone

First Posted

Study publicly available on registry

June 6, 2022

Completed
6 months until next milestone

Study Start

First participant enrolled

November 28, 2022

Completed
Same day until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 28, 2022

Completed
5 months until next milestone

Study Completion

Last participant's last visit for all outcomes

May 2, 2023

Completed
Last Updated

March 22, 2024

Status Verified

March 1, 2024

Enrollment Period

Same day

First QC Date

June 2, 2022

Last Update Submit

March 20, 2024

Conditions

Keywords

Fibrous dysplasiaquality of life

Outcome Measures

Primary Outcomes (2)

  • FD Qualitative study: notions on quality of life

    quality of life concepts that will emerge during group interviews.

    during group interview (90 minutes)

  • FD Quantitative study: scores of quality of life and olfaction impairment

    quality of life measured with SF36 score. Patients will answer to 11 questions. Olfaction impairment measured with SELF-MOQ olfaction score. Patients will answer to 14 questions

    during 30 minutes

Study Arms (3)

FD qualitative study on quality of life.

FD patients (FD monostotic, FD polyostotic, with or without craniofacial damages) will be invited to attend a focus group on the following themes: symptoms, self-image, psychological and emotional well-being, difficulties in daily life and adaptative strategies. The focus-groups will be conducted in a semi-directive manner by a moderator and will be recorded; after a verbatim transcription of the focus group recordings, the data will be analyzed manually and with the help of a semantic analysis software. It will allow common notions about quality of life in FD to emerge. A demographic questionnaire will also be completed by the participants.

Other: FD qualitative study on quality of life

FD quantitative sudy on quality of life and olfaction.

Participants will receive two questionnaires to complete: the SF36 questionnaire (quality of life) and the SELF-MOQ questionnaire (olfaction impairment evaluation). Other data required for the study will be extracted from the medical record: age, weight, height, affected bone sites, Radiological/ biological activity data, sensorial deficit, medication. A demographic questionnaire will also be completed.

Other: FD quantitative sudy on quality of life and olfaction.

FD qualitative and quantitative study on quality of life and olfaction.

Patients will be invited to attend a focus group on quality of life (qualitative study) as described for group 1 and to complete questionnaires on quality of life and olfaction (quantitative study) as described for group 2

Other: FD qualitative study on quality of lifeOther: FD quantitative sudy on quality of life and olfaction.

Interventions

Patients will be contacted and focus groups will be organized with 6 to 8 patients presenting different types of FD: monostotic, polyostotic, with or without craniofacial damage. Several focus-groups will be conducted with men only or women only. Patients will be led in a semi-directive manner by a moderator who will use an interview grid listing all the topics to be addressed: symptoms, self-image, psychological and emotional well-being, difficulties in daily life and adaptative strategies. The discussions will be recorded and transcribed verbatim. Data will be analyzed manually by 2 investigators and with the help of a semantic analysis software. The objective is to bring out common notions about the quality of life of patients, their psychological and emotional well-being, their difficulties in daily life and their coping strategies according to their condition. Differences or similarities between men and women will be investigated.

FD qualitative and quantitative study on quality of life and olfaction.FD qualitative study on quality of life.

Participants will receive 3 questionnaires to complete: the SF36 questionnaire (quality of life), the SELF-MOQ questionnaire (olfaction evaluation) and a demographic questionnaire. Other data required for the study will be extracted from the medical record: age, weight, height, affected bone sites, Radiological/ biological activity data, sensorial deficit, medication. For each questionnaire, scores will be calculated and compared between the different FD patient populations according to sex, age and type of FD.

FD qualitative and quantitative study on quality of life and olfaction.FD quantitative sudy on quality of life and olfaction.

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Primary care clinics: adults coming for consultation or hospitalization for fibrous dysplasia in Hopital Edouard Herriot rheumatology department in Lyon, France.

You may qualify if:

  • Men and women
  • years and more
  • with Fibrous dysplasia
  • Being followed in the rheumatology Department of the E. Herriot Hospital in Lyon.
  • Non-opposition to take part in the study
  • written consent to the audio recording of the discussions.

You may not qualify if:

  • Legal incapacity or limited legal capacity
  • Psychiatric or neurological condition that severely impairs comprehension
  • Difficulty understanding spoken French
  • Patients with another pathology with a major impact on quality of life

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Edouard Herriot Hospital - rheumatology

Lyon, 69003, France

Location

MeSH Terms

Conditions

Fibrous Dysplasia of Bone

Interventions

Smell

Condition Hierarchy (Ancestors)

OsteochondrodysplasiasBone Diseases, DevelopmentalBone DiseasesMusculoskeletal Diseases

Intervention Hierarchy (Ancestors)

SensationNervous System Physiological PhenomenaMusculoskeletal and Neural Physiological Phenomena

Study Officials

  • Roland CHAPURLAT, Pr

    Hospices Civils de Lyon

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
CASE ONLY
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

June 2, 2022

First Posted

June 6, 2022

Study Start

November 28, 2022

Primary Completion

November 28, 2022

Study Completion

May 2, 2023

Last Updated

March 22, 2024

Record last verified: 2024-03

Locations